Genetic Testing Reveals New Drug Targets in Esophageal Cancer
Study findings suggest a potential role for the use of targeted therapy in addition or as an alternative to conventional treatment in patients with esophageal cancer.
Read MorePosted by Elaine Sanchez Wilson | Oct 16, 2015 | Research |
Study findings suggest a potential role for the use of targeted therapy in addition or as an alternative to conventional treatment in patients with esophageal cancer.
Read MorePosted by Steve Halasey | Jan 12, 2015 | Research |
Under a new agreement, Interleukin Genetics will provide genetic profiling for a clinical trial evaluating Isis-APO(a)Rx for patients with high lipoprotein(a).
Read MorePosted by Jenny Lower | Oct 31, 2014 | Molecular Diagnostics |
Genetic tests are increasingly being used in clinical laboratories to look for changes in an individual’s chromosomes or genes that lead to health problems or may increase the risk of developing a health problem.
Read MorePosted by Judy O'Rourke | Oct 15, 2013 | Breast, Cancer, Molecular Diagnostics, Unknown Origin & Other Cancer Types |
Quest also releases results from a national Harris survey revealing widespread confusion about BRCA testing.
Read MorePosted by Judy O'Rourke | May 8, 2013 | Cardiovascular, Molecular Diagnostics |
The newly validated tests cover the major causes of cardiomyopathies, arrhythmia disorders, and other genetically transmitted diseases that affect the heart and vasculature.
Read More